Noninvasive evaluation of nonalcoholic steatohepatitis (NASH)

被引：1
|
作者：
Mansour-Ghanaei, Fariborz [1 ]
Vahhabi-Moghaddam, Masrour [2 ]
Joukar, Farahnaz [1 ]
Asgharnezhad, Mehrnaz [1 ]
Kiyani, Noufar [2 ]
机构：
[1] Guilan Univ Med Sci, GLDRC, Rasht, Iran
[2] Guilan Univ Med Sci, Poursina Hosp, Dept Radiol, Rasht, Iran
来源：
CASPIAN JOURNAL OF INTERNAL MEDICINE | 2013年 / 4卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：797 / 798
页数：2
相关论文
共 50 条
  • [21] NASH (Nonalcoholic steatohepatitis): A case of multiorganelle failure
    Caldwell, Stephen
    FREE RADICAL BIOLOGY AND MEDICINE, 2014, 75 : S6 - S6
  • [22] Nonalcoholic steatohepatitis (NASH): Mechanism of hepatotoxic sensitivity
    Donthamsetty, S
    Bhave, VS
    Mitra, M
    Mehendale, H
    Latendresse, J
    FASEB JOURNAL, 2006, 20 (05) : A1380 - A1380
  • [23] Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH)
    Qi, Xiaoyan
    Lai, Jinping
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [24] The burden of nonalcoholic steatohepatitis (NASH) in the United States
    Elliot B. Tapper
    Nancy Krieger
    Raymond Przybysz
    Nate Way
    Jennifer Cai
    Dion Zappe
    Sarah Jane McKenna
    Garth Wall
    Nico Janssens
    Maria-Magdalena Balp
    BMC Gastroenterology, 23
  • [25] Validation of Fractional Synthesis Rate of Plasma Lumican As a Noninvasive Marker of Fibrogenesis in Patients with Nonalcoholic Steatohepatitis (NASH)
    Loomba, Rohit
    Lawitz, Eric J.
    Gene, Edward J.
    Ruane, Peter J.
    Zhang, Jie
    Wang, Lulu
    Chen, Guang
    McColgan, Bryan John
    Chung, Chuhan
    Subramanian, Mani
    Myers, Robert P.
    Middleton, Michael S.
    Noureddin, Mazen
    Harrison, Stephen A.
    Li, Kelvin W.
    Hellerstein, Marc
    HEPATOLOGY, 2018, 68 : 986A - 986A
  • [26] VALIDATION OF HISTOLOGIC AND NONINVASIVE MEASURES OF FIBROSIS AS SURROGATE ENDPOINTS OF DISEASE PROGRESSION IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)
    Anstee, Quentin M.
    Trauner, Michael H.
    Lawitz, Eric J.
    Bzowej, Natalia
    Vuppalanchi, Raj
    Younes, Ziad
    Ding, Dora
    Li, Georgia
    Kersey, Kathryn
    Camargo, Marianne
    Djedjos, Stephen
    Subramanian, Mani
    Myers, Robert P.
    Wong, Vincent Wai-Sun
    Harrison, Stephen A.
    Okanoue, Takeshi
    Romero-Gomez, Manuel
    Goodman, Zackary
    HEPATOLOGY, 2019, 70 : 1342A - 1343A
  • [27] GLYMPSE LIVER TEST FOR NONINVASIVE MONITORING OF COMBINATION DRUG THERAPY IN A RAT MODEL OF NONALCOHOLIC STEATOHEPATITIS (NASH)
    Cazanave, Sophie
    Pacula, Maciej
    Zagorska, Anna
    Warren, Andrew
    Sherman, Sarah
    Huang, Eric K.
    Walker, Katie
    Liu, Kathy
    Lopez, David
    Newstrom, David
    Zaboli, Shiva
    Bates, Jamie
    Liles, John
    Budas, Grant
    Breckenridge, David
    Billin, Andrew
    Kwong, Gabriel
    HEPATOLOGY, 2019, 70 : 1028A - 1029A
  • [28] Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH
    Del Ben, Maria
    Overi, Diletta
    Polimeni, Licia
    Carpino, Guido
    Labbadia, Giancarlo
    Baratta, Francesco
    Pastori, Daniele
    Noce, Valeria
    Gaudio, Eugenio
    Angelico, Francesco
    Mancone, Carmine
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (02)
  • [29] Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
    Duarte, Sebastiao M. B.
    Stefano, Jose Tadeu
    Oliveira, Claudia P.
    ANNALS OF HEPATOLOGY, 2019, 18 (03) : 416 - 421
  • [30] Noninvasive diagnosis of nonalcoholic steatohepatitis:Emerging approaches
    Qin Pan
    Jian-Gao Fan
    Hepatobiliary & Pancreatic Diseases International, 2019, 18 (01) : 1 - 3
12345